EUVIMEDEUVIMED entdecken
Crossref

Ghrelin alleviates liver fibrosis by triggering HSCs ferroptosis via regulating injured hepatocyte‐derived exosomal LncMALAT1 / GPX4 pathway

Xin Luo iD, Kan Chen iD, Jie Zhang iD, Zhilu Yao iD, Chuanyong Guo iD, Ying Qu iD, Lungen Lu iD, Yuqing Mao iD

The FASEB Journal · 2025

DOI: 10.1096/fj.202401985rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Xin Luo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Ghrelin, Ferroptosis, Liver Cirrhosis, Hepatic Stellate Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ghrelin is a gastric peptide that modulates various biological functions, including potential anti‐inflammatory and antifibrotic properties. Increasingly evidence have demonstrated that exosomes derived from injured hepatocytes (IHC‐Exo) can accelerate the activation of hepatic stellate cells (HSCs) and liver fibrosis. Ferroptosis, a type of novel programmed cell death, regulates diverse pathological processes, including liver fibrosis. However, it remains unclear whether ghrelin exerts its antifibrotic effect through mechanisms involving exosomes and ferroptosis. To explore the mechanism, IHC‐Exo were isolated from supernatant of injured mouse primary hepatocytes (HCs) treated with palmitic acid (PA). Mouse primary HSCs and a bile duct ligation (BDL)‐induced liver fibrosis murine model were then treated with IHC‐Exo or exosomes derived from ghrelin‐pretreated injured hepatocytes (GHR‐IHC‐Exo). The expression of α‐SMA, Collagen I and long noncoding (lnc) RNA MALAT1 in HSCs were then detected. The ferroptosis of HSCs was evaluated by assessing the level of CCK8, MDA, GSH, and GPX4 expression. Mouse serum and liver biopsy samples were used to determine whether ferroptosis is involved in the progression of liver fibrosis. Nanoparticle tracking analysis and electron microscopy characterized the features of IHC‐Exo. As the results suggested, compared with IHC‐Exo, GHR‐IHC‐Exo treatment significantly promoted ferroptosis of HSCs, inhibited their activation, and consequently alleviated liver fibrosis progression in BDL mice. The inhibitory effect of GHR‐IHC‐Exo on activation of HSCs was partially reversed by treatment with the ferroptosis inhibitor Ferrostatin‐1. The expression of lncMALAT1 was significantly down‐regulated in GHR‐IHC‐Exo as compared to IHC‐Exo. Serum exosome levels of MALAT1 were significantly higher in patients with severe liver fibrosis compared to those with mild liver fibrosis. Additionally, the expression of ferroptosis suppressor protein GPX4 was elevated as liver fibrosis progression, indicating decreased ferroptosis of HSCs in patients with severe liver fibrosis. In conclusion, Ghrelin reduced the pro‐fibrotic effect of IHC‐Exo in liver fibrosis by regulating lncMALAT1/GPX4 pathway mediated HSCs ferroptosis. Triggering HSCs ferroptosis via GHR‐IHC‐Exo may become a novel strategy to alleviate the progression of liver fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GhrelinFerroptosisLiver CirrhosisHepatic Stellate CellsExosomesHepatocytesPhospholipid Hydroperoxide Glutathione PeroxidaseAnimalsMaleHumansMiceSignal TransductionMice, Inbred C57BL

Stichwörter der Autor:innen

exosomesferroptosisghrelinliver fibrosislncMALAT1

Substanzen

GhrelinPhospholipid Hydroperoxide Glutathione Peroxidase

Autor:innen und Institutionen

  • Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Gastroenterology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Department of Gastroenterology, Jing'an District Zhabei Central Hospital, Shanghai, China.

ORCID-Profile: Xin Luo, Kan Chen, Jie Zhang, Zhilu Yao, Chuanyong Guo, Ying Qu, Lungen Lu, Yuqing Mao

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • National Natural Science Foundation of China

Zitieren

APA

Luo, X., Chen, K., Zhang, J., Yao, Z., Guo, C., Qu, Y., Lu, L., & Mao, Y. (2025). Ghrelin alleviates liver fibrosis by triggering HSCs ferroptosis via regulating injured hepatocyte‐derived exosomal LncMALAT1 / GPX4 pathway. The FASEB Journal. https://doi.org/10.1096/fj.202401985rr

Vancouver

Luo X, Chen K, Zhang J, Yao Z, Guo C, Qu Y, et al. Ghrelin alleviates liver fibrosis by triggering HSCs ferroptosis via regulating injured hepatocyte‐derived exosomal LncMALAT1 / GPX4 pathway. The FASEB Journal. 2025. doi:10.1096/fj.202401985rr

BibTeX
@article{Luo2025,
  author = {Luo, Xin and Chen, Kan and Zhang, Jie and Yao, Zhilu and Guo, Chuanyong and Qu, Ying and Lu, Lungen and Mao, Yuqing},
  title = {Ghrelin alleviates liver fibrosis by triggering HSCs ferroptosis via regulating injured hepatocyte‐derived exosomal LncMALAT1 / GPX4 pathway},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202401985rr}
}
Kostenlos starten →